Advances in CAR-T Cell Therapy Across Hematologic Malignancies: From Pipeline to Clinical Practice

Download All
Download slides and view an on-demand webcast from a live symposium on best practices in using CAR T-cell therapies for leukemias, lymphomas, and myeloma.
Michael R. Bishop, MD
Program Director
person default
Jesús G. Berdeja, MD
Michael R. Bishop, MD
Jae H. Park, MD

Downloadable Slidesets

Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with lymphomas.

Michael R. Bishop, MD Released: December 10, 2021

Download this slideset for expert perspectives on optimal strategies in the use of CAR T-cell therapy for patients with multiple myeloma.

person default Jesús G. Berdeja, MD Released: December 10, 2021

Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with ALL, as well as a discussion of key toxicities associated with CAR T-cell therapy.

Jae H. Park, MD Released: December 10, 2021

Download this short summary slideset of key takeaway points from a live presentation on current best practices and emerging strategies in the use of CAR T-cell therapy.

person default Jesús G. Berdeja, MD Michael R. Bishop, MD Jae H. Park, MD Released: December 20, 2021

On-Demand Webcast

In this on-demand webcast of a live satellite symposium, expert faculty review the latest safety and efficacy data on CAR T-cell–based therapies for leukemias, lymphomas, and myeloma.

Michael R. Bishop, MD
Program Director
person default Jesús G. Berdeja, MD Jae H. Park, MD
Physicians: maximum of 2.25 AMA PRA Category 1 Credits Released: January 13, 2022 Expired: January 12, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings